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How mitochondrial DNA mutations clonally expand in an individual cell
is a question that has perplexed mitochondrial biologists for decades.
A growing body of literature indicates that mitochondrial DNA mutations
play a major role in ageing, metabolic diseases, neurodegenerative diseases,
neuromuscular disorders and cancers. Importantly, this process of clonal
expansion occurs for both inherited and somatic mitochondrial DNA
mutations. To complicate matters further there are fundamental differences
between mitochondrial DNA point mutations and deletions, and between
mitotic and post-mitotic cells, that impact this pathogenic process. These
differences, along with the challenges of investigating a longitudinal process
occurring over decades in humans, have so far hindered progress towards
understanding clonal expansion. Here we summarize our current under-
standing of the clonal expansion of mitochondrial DNA mutations in
different tissues and highlight key unanswered questions. We then discuss
the various existing biological models, along with their advantages and dis-
advantages. Finally, we explore what has been achieved with mathematical
modelling so far and suggest future work to advance this important area of
research.1. Evolutionary aspects of mitochondrial genetics
The endosymbiotic origins of mitochondria in eukaryotic cells are apparent in
the similarities between mitochondria and bacteria, such as the plasmid-like
multi-copy circular genome that resides in the mitochondrial matrix. Mitochon-
dria are thought to be descended from α-proteobacterium due to sequence
similarities between the genome and mitochondrial DNA (mtDNA) [1]. In
present-day humans the mitochondrial genome is approximately 16.5 kb and
encodes only 37 genes. This genome has been greatly reduced over evolution-
ary time via transfer of genes to the nuclear genome [2] so that it now only
encodes 2 rRNAs, 13 OXPHOS subunits and 22 tRNAs [3].
Unlike diploid nuclear DNA,mtDNA exists in a highly polyploid statewithin
each cell. Thismeans thatmutations in themtDNA can exist in a subset of the total
cellular mtDNA, a state termed ‘heteroplasmy’. mtDNAmolecules are replicated
during mitosis, in much the same way that nuclear DNA molecules are (defined
as strict replication [4]), but mtDNA molecules are also continuously replicated
independently of the cell cycle (defined as relaxed replication [4]), in a similar
fashion to the replication of bacterial genomes. Molecules of mtDNA have
been shown to be continuously selected at random for relaxed replication in
pulse-chase thymidine analogue experiments in dividing mouse cells [5].
Packaged as nucleoids, mtDNA resides close to the inner mitochondrial
membrane and the oxidative phosphorylation (OXPHOS) complexes. The mito-
chondrial genome is hyper-mutable compared with nuclear DNA and this is
thought to be due to damage caused by the high levels of reactive oxygen
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2species (ROS) to which it is exposed [6,7], as well as the fact
that mtDNA is replicated more frequently. Further, the com-
pact nature of mtDNA means that there is very little that is
non-coding and therefore mutations arising in mtDNA are
much more likely to have pathological impact than mutations
arising in the nuclear genome, where a large amount of the
DNA is intronic.
Mutations in mtDNA can either be inherited or
sporadically acquired throughout life. Inherited mutations
are randomly segregated between primary oocytes and
between different tissues. Work assessing mutation load in
different fetal tissues has demonstrated that mutation load is
similar across tissues [8]. Single cell analysis at this stage has
not yet been completed, so we have no way of knowing
whether the segregation of mutations during tissue formation
contributes to the variability ofmutation load orwhether this is
purely due to clonal expansion after development. In individ-
uals who inherit a low mutation load, mitochondrial disease
pathology is not likely to arise for a long time, if at all. The
timing of the onset of mitochondrial disease is variable and
pathology can be heterogeneous, affecting some tissues or
parts of tissues or cells, but not others [9,10].
In comparison, sporadically acquired mutations arise in a
single mtDNA molecule in a single cell and occur during
healthy ageing, mtDNA maintenance disorders and a range
of other diseases [11–13]. This single mutated mtDNA mol-
ecule is then either lost from the cell or clonally expands to
higher levels. There is a tissue-specific pattern to the clonal
expansion of sporadic mtDNA mutations: the accumulation
of mtDNA point mutations is more common in mitotic
cells whereas the accumulation of mtDNA deletions is more
common in post-mitotic cells. Up to three or four different
mtDNA deletions have been found to have clonally expanded
in single muscle fibres and neurons respectively [13–15],
although 37 mtDNA deletion species have been detected in a
single neuron by ultra-deep sequencing [13].2. Clonal expansion of mtDNA mutations
The dynamic process by which mtDNAmutations accumulate,
which we often term ‘clonal expansion’, is thought to be one of
the contributing factors behind the progress of many forms
of mitochondrial disease. Furthermore, evidence suggests that
the functional consequences of having clonally expanded
mtDNA mutations may contribute to pathogenicity in other
age-related diseases such as Parkinson’s disease [16]. As such,
this has become a very important question for mitochondrial
biologists to answer, since it presents a potential therapeutic
avenue that can be applied across a range of diseases.
2.1. Clonal expansion theories
One of the biggest unanswered questions regarding clonal
expansion is whether there is any selective advantage or driver
for the accumulation of mtDNA mutations. There have been a
series of theories developed to explain how clonal expansion
of mtDNA mutations occurs, with the random genetic drift
theory assuming no selective pressures [17,18], and ‘survival
of the smallest’ [19], ‘survival of the sickest’ [2,20], the negative
feedback loop [21,22] and the ‘perinuclear niche’ [23] all assum-
ing different possible selective mechanisms (figure 1). In silico
predictions have been made from several of these theoriesusing estimations of important biological variables such as
mtDNA copy number and mitochondrial turnover. All models
have their limits but provide a means to test the degree to
which a hypothesis can explain the levels of mitochondrial
dysfunction that are observed in human samples.
So far evidence suggests that random genetic drift by
relaxed replication is sufficient to explain the clonal expansion
of point mutations but not necessarily mtDNA deletions.
Random genetic drift suggests that mtDNA molecules are
selected randomly for strict or relaxed replication leading to
an accumulation of mutated mtDNA by chance. Stochastic,
dynamic simulation models of mtDNA population dyna-
mics during relaxed replication were previously developed
[17,18,24] to explain clonal expansion as a form of random gen-
etic drift [25]. Random genetic drift, which could explain clonal
expansion without relying on any selective advantage or feed-
back at all, has formed a useful null hypothesis for testing
theories about clonal expansion for the past 20 years.
In comparison with mtDNA point mutations, the clonal
expansion of mtDNA deletions does not seem to be fully
explained by random genetic drift, since results from
random genetic drift modelling work to date do not accu-
rately predict the levels of mtDNA deletions observed in
substantia nigra neurons and muscle fibres (discussed further
below). As such alternative hypotheses that include selective
pressures have been considered. The first theory suggested to
explain how mtDNA deletions expand clonally, suggesting
that deleted, and therefore smaller, mitochondrial genomes
would be replicated more quickly and so would have a selec-
tive advantage over wild-type genomes [19]. An alternative
hypothesis suggests that the driving mechanism is a link
between mtDNA encoded protein products and mtDNA
replication [21,22]. MT-ND4, MT-ND5 and MT-ND6 were
proposed as possible candidates for such a feedback mechan-
ism with an mtDNA deletion that encompassed these genes
leading to a decrease in their proteins and a compensatory
increase in mtDNA transcription and replication to replenish
these proteins. This increased replication would therefore
provide a possible selective advantage for the deleted
mtDNA. Subsequently observations in muscle have
suggested that close proximity to nuclei provides a similar
feedback mechanism for mtDNA deletions upregulating
mtDNA replication, but through retrograde stress signalling
for example changes in ATP/ADP or NAD+/NADH ratios
[23]. Both the positive transcriptional feedback loop and peri-
nuclear niche hypothesis could feasibly contribute to clonal
expansion of mtDNA point mutations also, however evi-
dence suggests these selective pressures are not needed for
clonal expansion. Similarly, it also remains possible that pre-
dictions from an adjusted random genetic drift model, fully
incorporating uncertainty about parameters such as mtDNA
copy number, mtDNA turnover and mitochondrial dynamics,
will not be significantly different from observations in
human samples.3. Population dynamics of mtDNA point
mutations
3.1. Formation of point mutations
The mechanism by which mtDNA point mutations are
generated in somatic tissues is an area of much debate. Initial
random genetic drift replicative advantage
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Figure 1. Theories of clonal expansion. The mechanism by which clonal expansion happens has been proposed to be explain by a number of possible theories about
the mechanism. Random genetic drift suggests the accumulation happens randomly during relaxed mtDNA replication. A replicative advantage suggests that smaller
deleted mtDNA genomes are replicated faster and take over the cell. Survival of the sickest suggests that the most dysfunctional mitochondria survive mitophagy due
to a reduced production of ROS and therefore accumulate. A negative feedback look suggests a reduction in a mtDNA encoded protein product from a mutated
mtDNA molecule drives further transcription and replication. Finally, the perinuclear niche hypothesis suggests a localized upregulation of mitochondrial biogenesis is
triggered by mtDNA mutations accumulating adjacent to the myonuclei in muscle fibres.
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3hypotheses suggested that mtDNAwas susceptible to damage
induced by ROS due to its close proximity to the respiratory
chain in the mitochondrial matrix [26]. ROS induced DNA
damage causes base modifications, double and single-strand
breaks, sugar damage and abasic sites [27]. The most com-
monly reported base lesions are thymine glycols and 7,8-
dihydro-8-oxo-20-deoxyguanosine [8-oxo-dG] [28]. 8-oxo-dG
is thought to be the most mutagenic lesion, which can cause
the mtDNA polymerase to mis-incorporate an A base opposite
the oxidized G resulting in a G:C to T:A transversion following
a second round of replication [28]. More recent analysis of
mtDNA mutational spectra in ageing cells has revealed that
it is not consistent with the predicted ROS induced damage
pattern, instead the most commonly reported mutations are
G:C to A:T transitions [29,30]. Transitions are more likely tobe the result of errors of the Polγ, which is responsible for repli-
cation of the mtDNA, and/or spontaneous cytosine
deamination to uracil which then mis-pairs with adenine
resulting in the G>A transition [31]. These data, alongside
analysis of mtDNA point mutation spectra in transgenic ani-
mals [32], suggest there is a limited role for ROS-induced
mtDNAmutagenesis causing point mutations in somatic cells.
3.2. Sporadic mtDNA point mutations
Sporadically acquired mtDNA point mutations, are the most
common clonally expanded mutations in mitotic tissues.
Thesewere first detectedbyNekhaeva et al. [33],who sequenced
individual cells from normal ageing buccal epithelium and
found that a subset of cells contained mtDNA point mutations
royalsocietypublishing.org/journal/rsob
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4at high levels. Following this, Taylor et al. showed that a signifi-
cant proportion of ageing colonic epithelial crypts (on average
15% by the age of 70) demonstrated histochemical loss of cyto-
chrome c oxidase activity, which was caused by somatic,
clonally expanded mtDNA mutations [10]. This work was
followed up by a number of studies demonstrating an age-
related increase in the frequency of cells with OXPHOS defects
due to clonally expanded mtDNA mutations in mitotic tissues
including the small intestine, stomach, oesophagus, prostate
and liver [34–37].
Computational modelling of clonal expansion within mito-
tic cells has shown that random genetic drift is sufficient to
explain the population dynamics of mtDNA point mutations
observed experimentally in individual cells over time [24,38].
Random genetic drift models suggest that clonal expansion of
amutatedmtDNAmolecule to high levels within a cell is a rela-
tively slow process and that initial mutational events must
occur early in life. These early life mutations then either propa-
gate randomly through mtDNA replication and segregation at
cell division, or are lost. Successive cycles of this stochastic pro-
cess allowmutatedmtDNAmolecules to become the dominant
species within some cells, resulting in a mosaic pattern of cellu-
lar OXPHOS defects which are seen in ageing human mitotic
tissues. In addition, most mitotic tissues have a high turnover
rate and are maintained by long-lived stem cells. mtDNA
mutations which expand clonally within these stem cells
will then be propagated in their progeny. In tissues such as
the liver, prostate, stomach and colon, this results in large,
clonal patches of cells with identical mtDNA mutations and
associated OXPHOS defects [34,36,38,39].
Despite numerous studies providing evidence that
mtDNA mutations expand clonally causing a mosaic pattern
of OXPHOS defects in ageing human tissues (e.g. colon;
figure 2), the functional consequences of these have not yet
been fully elucidated. A study by Nooteboom et al. showed
that colonic crypts with loss of MTCO1 protein expression
had fewer actively proliferating cells and were significantly
smaller than those with normal MTCO1 levels, however
whether this further effects tissue function is unknown [40].
Further insights have been possible through the development
of mouse models. The mtDNA mutator mouse has a D257A
amino acid change in the proof-reading domain of Polγ result-
ing in an error prone polymerase, causing an accelerated
acquisition of mtDNA point mutations [41,42]. These mice
show a premature ageing phenotype and significantly reduced
lifespan. A mosaic pattern of OXPHOS defects due to clonally
expanded mtDNA mutations have been shown in the small
intestine [43] and the colon of thesemice [44]. In the small intes-
tine these defects have been shown to cause an increase in the
frequency of apoptosis, a decrease in cell proliferation, a
reduction in dietary fat absorption and a loss of the capacity
to form stem cell derived organoids in vitro [45]. Analysis of
the haematopoietic compartment of the mutator mice revealed
no direct effect of mitochondrial dysfunction on the haemato-
poietic stem cells themselves, but instead defects during early
differentiation were noted [46]. These differentiation blocks
resulted in abnormal myeloid lineages and caused anaemia
and lymphopaenia in the mice [47].
3.3. Inherited mtDNA point mutations
In contrast to the accumulation of somatic mtDNA mutations
in ageing tissues, some inherited mtDNA point mutations arefound to be systematically lost throughout life in rapidly
dividing cells including blood, buccal mucosa and colonic
epithelium, while remaining stable in post-mitotic tissues
[48–52]. However, it is not known whether the decline in
mtDNA mutation load in rapidly dividing cells is also the
result of random genetic drift or the result of active selection
against functionally deleterious variants (e.g. due to the loss
of entire affected cells).4. Population dynamics of mtDNA
deletions
4.1. Deletion formation
mtDNA deletions have been proposed to form either during
replication or repair. Features ofmtDNAbreakpoints have pre-
viously been used to infer the mechanism of formation, with
deletions defined as class I if they have direct repeats, class II
with indirect repeats and class III if they have no repeats [53].
Initially deletions were proposed to form during replication
due to a slip-replication mechanism [54]. This model assumes
that mtDNA is replicated by the strand-asynchronousmechan-
ism and that the light strand misaligns so that the 30 repeat of
the light strand anneals to the 50 end of the heavy strand, gen-
erating a single strand loop, this loop would be susceptible to a
single strand break and degradation [54,55]. An alternative
hypothesis was later proposed, which suggests mtDNA
deletions are formed during mtDNA repair of double strand
breaks, by the annealing of homologous repeats created by
exonuclease activity at double strand breaks [53,55].
To further investigate replication-dependent mechanisms
for deletion formation, a mouse model with an inducible mito-
chondrially targeted restriction endonuclease [56] led to the
suggestion that mtDNA deletions are formed during mtDNA
repair of double-strand breaks. In these mice double-strand
breaks were induced in adult neurons, resulting in the for-
mation of deleted mtDNA molecules. Evidence suggests that
double-strand breaks may be repaired either by non-homolo-
gous end joining or micro-homology-mediated end joining
[55–58]. Both of these mechanisms only account for
homology-dependent recombination, whereas there are
reports of deletions without repeat sequences [17,53]. More
recent work looking at replication-dependent mechanisms
has suggested that mtDNA deletions are instead formed by
copy-choice recombination during active L-strand DNA syn-
thesis [59]. This model is attractive since mtDNA deletions
with direct repeats, imperfect repeats and no repeats have
been detected and while this mechanism is enhanced by the
presence of mtDNA repeats it can also occur without repeats.
As such it is now thought that mtDNA deletions form either
by copy choice recombination during mtDNA replication or
by repair of double strand breaks via non-homologous end
joining or micro-homology mediated end joining [60]. Further-
more, themechanism for deletion formationmay be dependent
on the mechanism of mtDNA replication, which has been
demonstrated to vary between tissues [61].
4.2. Sporadic mtDNA deletions
In contrast to mtDNA point mutations, sporadically acquired
mtDNA deletions are the most common sporadic, clonally
expanded mtDNA mutation in post-mitotic cells. The reason
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Figure 2. Consequences of clonally expanded mitochondrial DNA mutations. Mitochondrial DNA mutations accumulate with age and disease in both mitotic tissues such
as the colon, and post-mitotic cells such as muscle fibres and neurons. At low levels the mitochondrial DNA mutation will have little functional impact (COX positive). As the
percentage of mitochondrial DNA mutations within a cell accumulate they will exceed a biochemical threshold causing mitochondrial respiratory chain dysfunction (COX
deficient). The transition from COX positive to COX deficient is slightly different in different tissues, with the most noticeable differences being that colonic crypts can be
partially COX deficient, muscle fibres can have focal deficiency, whereas neurons are more commonly observed to have low deficiency across the full cell body (although it is
never possible to view a full neuron). Scale bar, 25 µm. The images were collected from the authors’ own research; see ethics statement at end of article for further details.
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5for this contrast remains an important unsolved mystery. High
levels of clonally expanded mtDNA deletions have been
reported in neuronal populations from the substantia nigra,
hippocampus, striatum and spinal cord with both ageing
and disease [12,62–64], as well as aged skeletal muscle fibres
[65]. These mtDNA deletions accumulate to high levels in
both neurons and muscle fibres, leading to mitochondrial
dysfunction. However, the mutation loads observed in differ-
ent neuronal populations differ substantially, with the highest
levels (over 50%) typically observed in the dopaminergic
neurons of the substantia nigra [66,67].
Extensive studies have demonstrated that clonally
expanded mtDNA deletions are associated with mitochon-
drial OXPHOS dysfunction in both neurons and muscle
fibres [9,65] (figure 2). Furthermore, in the brain these have
been found to be associated with neurodegeneration [62],
and there is evidence that they are associated with muscle
fibre atrophy [65]. Despite increasing knowledge about the
consequences of clonally expanded mtDNA deletions, it is
not yet fully understood how these deleted mtDNA species
come to predominate in cells.
While much is known about mitochondrial genetics, the
process by which a single mtDNA mutation accumulates still
eludes us. Based on data from estimates of mtDNA turnover
rate and mtDNA copy number from rat muscle fibres, model-
ling of random genetic drift by Elson et al. [18] predicts 4% of
post-mitotic cells should become COX-deficient over an 80
year period in healthy individuals. However, that prediction
does not include a range of uncertainty or confidence interval.
Data from human substantia nigra shows that respiratory
chain deficiency is higher with 40% of neurons found to beCOX-deficient at 80 years [68,69], and this is likely to be an
underestimate since approximately 5% of neurons are lost per
decade [70]. Levels of COX-deficient cells in a single section of
aged muscle are much lower with percentage of COX-deficient
fibres typically less than 5% in people aged 75–88 years [71].
However when the length of muscle fibres in the quadriceps
vastus lateralis is considered, the true percentage may be
higher, approximately 6% at 49 years and approximately 31%
by the age of 92 years [65]. Again, there is considerable unstated
uncertainty about these predictions.
However, as well as assuming random genetics, the
model of Elson et al. [18] also assumes that fibres are well
mixed (i.e. it ignores diffusion of mtDNA along the consider-
able length of muscle fibres). If this model of random genetic
drift underestimates the percentage of respiratory chain
deficient cells, it may be that there are selective pressures at
work that are preferentially allowing the accumulation of
these deleted mtDNA species.
An alternative to purely random drift is that deleted
mtDNA molecules have a replicative advantage [19]. Many
studies in vitro have generated supporting evidence for this
theory, finding that deleted mtDNA molecules repopulate
cells faster than wild-type mtDNA under relaxed copy
number control [72,73]. However, following artificial depletion
of the mtDNA, the cell may replicate its mtDNA at a faster rate
in order to return to the required mtDNA copy number, under
such conditions the time taken to replicate a single molecule
could be much more rate limiting and therefore important,
than it would be in post-mitotic cells. For example, work
in human muscle has demonstrated no relationship between
the size of mtDNA deletions and respiratory chain deficient
royalsocietypublishing.org/journal/rsob
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6segments, suggesting that there is no replicative advantage [9].
However, we do not knowwhen each of themutations formed,
but must assume that if deletions form randomly with a mix
of small and large deletions this should not impact results.
Finally, work in C. elegans examining the behaviour of two dif-
ferently sized mtDNA deletions, also found no evidence for a
replicative advantage [74].
Another alternative hypothesis that has been proposed is
a feedback mechanism whereby low levels of protein pro-
ducts from the deleted genes, triggers mtDNA replication
[21,22]. While this hypothesis is attractive, the authors
suggest a subset of ‘feedback genes’. However, examination
of the spectrum of breakpoints reported on ‘mitobreak’ [75]
demonstrates that no one gene is always deleted and
indeed deletions occur that do not remove any of the
suggested genes. Therefore, if such a mechanism exists, it is
likely that the number of genes contributing to the feedback
mechanism is either larger or all inclusive.
More recently, we have proposed a perinuclear niche
hypothesis for the clonal expansion of deletions in skeletal
muscle. This stems from the observation that the smallest
regions of respiratory chain deficiency are both subsarcolem-
mal and perinuclear. The hypothesis suggests that the close
proximityof themtDNAdeletion anddysfunctionalmitochon-
dria to the nucleus provides a driver of clonal expansion
through retrograde stress signalling triggering a local increase
in mtDNA replication. Such stress signalling may include a
reduction in ATP/ADP or NAD+/NADH ratios, upregulation
of the integrated mitochondrial stress response [76] or (as
suggested in the original investigation) upregulation of mito-
chondrial biogenesis via the unfolded protein response [23].
Furthermore, if mtDNA replication is higher in the perinuclear
region of muscle fibres as previously reported in HeLa cells
[77], this may also lead to a higher frequency of replication
errors and deletion formation in the perinuclear mitochondria.
The perinuclear hypothesis would likely favour sporadic
mutations arising in close proximity to the nucleus, and there-
fore it is possible that it would also favour mtDNA point
mutations. However, point mutations are less commonly
investigated in muscle and further work would need to be
completed to investigate this.
This hypothesis only suggests a selective pressure after the
mtDNA deletion has reached sufficient levels locally to cause
respiratory chain deficiency, and it has yet to be determined
whether such an advantage is sufficient to explain the high
levels of respiratory chain deficient cells observed. However,
it is also possible that such focal deficiency could formwithout
an induction of replication if mtDNA replication is naturally
higher in the perinuclear region, as previously suggested
[77]. In muscle, the mitochondria are either packed around
the edge of the fibre adjacent to the myonuclei or between
the myofibrils [78] and as such transport is minimal with mito-
chondrial fission and fusion providing the main means for
distribution of mtDNA and proteins throughout the cell [79–
81]. These attributes of mitochondrial organization and
dynamics, as well as muscle fibre structure are integral to the
perinuclear hypothesis. Therefore while we cannot yet rule
out the existence of a similar mechanism in neurons, it is poss-
ible that an alternate mechanismmay be present in neurons, in
spite of perinuclear replication, given themore dynamic nature
of the mitochondria in this cell type.
In comparison with muscle, the mitochondria in neurons
must be transported from the site of biogenesis to areas ofhigh energy demand (e.g. the synapse and nodes of Ranvier)
and subsequently to the site of degradation. The majority of
mitochondria are found to be stationary at the sites of ATP
requirement, with around 10–20% of mitochondria being
actively transported [82]. This small proportion of moving
mitochondria and the sites at which mitochondrial biogenesis
and degradation occur are likely to be important factors when
we are considering howmtDNAmutations clonally expand in
neurons. Previously, it has been demonstrated that when mito-
chondria lose their membrane potential they are transported
back to the cell body for degradation [83,84], this is further sup-
ported by a lack of mitophagy observed in dendritic arbours
and axonal projections in mitoQC mice, with the majority of
mitochondrial degradation observed in the soma [85]. Further-
more, if the majority of mtDNA replication occurs in close
proximity to the nucleus as previously reported in cultured
cells [77], it is likely that the site of clonal expansion is in the
cell body with mtDNA mutations being distributed along the
neuron by mitochondrial transport, fission and fusion.
In muscle the presence of perinuclear foci of mitochondrial
dysfunction suggests that the nuclei play an important role in
the accumulation of mtDNA deletions and mitochondrial dys-
function. Therefore, the perinuclear niche hypothesis shows
promise for explaining how these mtDNA deletions accumu-
late. However, it will be necessary to understand the relative
contributions of mtDNA replication and mito-nuclear signal-
ling to this process and to systematically compare this to
random genetic drift using in silico modelling (discussed in
more detail below). The structure of neurons would favour a
situation where the majority of mitochondrial replication
would occur in the perinuclear area and thus would also sup-
port a similar perinuclear niche hypothesis for the clonal
expansion of mtDNA deletions to that proposed for muscle.
However, this is less definitively described in neurons than
muscle and also needs to take into consideration the vastly
different movement and dynamics of mitochondria within
these two cell types. This may explain why perinuclear focal
deficiency has not to date been reported in neurons; however,
it is still possible that such focal deficiency occurs and is
simply less frequent or more challenging to find.4.3. Single, large-scale mtDNA deletions
Similar to mtDNA point mutations, there is a disparity in what
happens for inherited and sporadically acquired mtDNA del-
etions. Inherited mtDNA deletions such as those in patients
with Pearson’s syndrome are also lost from the blood [86].
However, it does appear in post-mitotic tissues that inherited
mtDNAdeletions loads aremaintained throughout life or clon-
ally expand. High levels of mtDNA deletions have been
detected in individual muscle fibres and are associated with
respiratory chain deficiency [87]. High levels of inherited
mtDNA deletions have also been detected in neurons [88].5. Important challenges and unanswered
questions
Despite interest in understanding clonal expansion during
development and ageing, and in disease, there are several
important challenges that have hindered progress in under-
standing this important mechanism. Furthermore, there are
royalsocietypublishing.org/journal/rsob
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7manyunanswered questionswhich are inherently important for
understanding clonal expansion.
5.1. How does clonal expansion occur during
development?
Asstatedaboveweknowthat inheritedmtDNAvariants are seg-
regated unevenly between oocytes and that in a foetus tissue
homogenates have a similar mtDNA mutation load [8]. How-
ever we know little about the formation of somatic mutations
in utero, or about the single-cell mutation loads in fetal tissues.
The question of clonal expansion during development in utero
presents many unknown parameters for which it is all but
impossible for us to gather biological data independently,
making it clear that there is an important role for mathematical
modelling of our uncertainty about this process. We can build
hypotheses about how inherited mutations expand from the
initial condition of the progenitor oocyte and how new
mutations arise duringdevelopment and compare the predicted
consequences (e.g. mutation load distributions in fetal samples)
with observations. However, it is important to be explicit about
ouruncertaintyaboutmodelparameters suchas initialmutation
load, replication rate and copy number control, many of which
are difficult or impossible tomeasure directly,without assuming
a model of how expansion happens.
5.2. Why do mitotic cells and post-mitotic cells differ?
As discussed above, somatic mtDNA point mutations tend to
accumulate inmitotic cells,while somaticdeletionspredominate
inpost-mitotic cells. Thekey towhy this difference in theappear-
ance ofmtDNAmutations exists is likely to lie in the differences
between the two types of cell. In mitotic tissues, mtDNA
undergoes both strict (frequent) and relaxed (infrequent) repli-
cation, whereas in post-mitotic tissues, only relaxed replication
occurs.As such thismeans thatmtDNA ismore frequently repli-
cated in mitotic cells than post-mitotic cells. In addition, in
replicating cellsmitochondria are segregated to different daugh-
ter cell populations resulting in an asymmetric or symmetric
distributionofmutantmtDNAbetweendaughtercells, allowing
for a bottleneck effect impacting clonal expansion [38].
Cells in mitotic tissues are regularly turned over and
undergo apoptotic cell death. In comparison, in multinucleated
skeletal muscle fibres it is thought that apoptosis occurs for
single nuclei within a muscle fibre leading to muscle fibre atro-
phy [89], although this hypothesis is contentious [90]. Satellite
cells may also fuse with a muscle fibre allowing regeneration
of the fibre [91]. Both of the regeneration and apoptotic
processes are effectively sub-cellular, and as such, a whole cell
(and indeed the whole population of mitochondria in a
muscle fibre) is not removed on a periodic basis. In neurons
where cell death occurs during neurodegeneration, there is lim-
ited means to replace cells that are lost. Some neuronal
populations in particular show a steady decline overtime [70],
it is not understood why these are lost but it may be these are
the ones with the highest mutation load.
5.3. How do inherited and acquired mutations differ?
There are clear differences between the changes in sporadic
mtDNA mutations and inherited mtDNA mutations over
time. Inherited mtDNA mutations are lost in rapidly dividingcells such as the blood, intestinal epithelium, buccal mucosa
and urine [49–52,92]. In post-mitotic cells not much is known
about what happens to inherited mtDNA point mutations
overtime, but it is commonly believed that single, large-scale
mtDNA deletions clonally expand from birth in skeletal
muscle fibres [9] and neurons, with higher mtDNA deletion
loads in post-mitotic tissues than in mitotic tissues of the
same patient [93,94]. In comparison both somatic mtDNA
point mutations and mtDNA deletions clonally expand over
time. It has been hypothesized that, in neurons this accumu-
lation of somatic mutations, may be due to a difference in
how cells respond to a mutation that is acquired in comparison
to one that has been inherited [95]. Such a hypothesis is
intriguing and warrants investigation in other tissues.
5.4. How do we investigate a process that takes place
over a lifetime?
One of the greatest problems is that the accumulation of
mutatedmtDNA to pathological levels usually occurs over dec-
ades in humans. However, the most direct observations we can
make are cross-sectional observations in patient tissue. Further-
more, clonal expansion is dynamic and is heterogeneous,
occurring independently in individual cells. In order to capture
this heterogeneity, observation of many single cells is required.
However, even if it were possible to revisit the same cell repeat-
edly in vivo, it is not possible to track all of the individual
mtDNA molecules within a cell over time. Direct, longitudinal
observation of clonal expansion is simply not possible.
One helpful approach has been to examine spatial pat-
terns within tissues (e.g. subcellular location of respiratory
chain deficiency). From such studies we can deduce presence
and location of mutations in single cells [9,23], and make
deductions or predictions as to how these arose. It is difficult
to know what happened prior to the sample being collected
and it is important that we incorporate that uncertainty into
our predictions.
Given the practical constraints on making longitudi-
nal observations throughout human lifespans, in order to
understand clonal expansion, we need to work with a model
system. Importantly, the goal of anymodel (mathematical, stat-
istical or biological) is that it should be a simpler,more tractable
version of the real system, capturing its main characteristics.
Models do not need to replicate the target system exactly in
order to be useful, provided the differences are considered
when interpreting the results. It is important that we carefully
choose models appropriate for the question at hand.6. Modelling clonal expansion
6.1. Biological models
Examining mtDNA population dynamics in mitotic cell cul-
ture has a number of advantages, including the use of
patient-specific human cells, which are an experimentally tract-
able model of clonal expansion during development. For
example, with mitotic cell culture it is possible to observe
point mutations arising, reaching loads as high as 25% and
declining in continuously dividing cell culture in as little as
21 weeks [96]. However, there are substantial disadvantages
to such culture based models, including: time scale (although,
in principle, cells can be cultured almost indefinitely); the
royalsocietypublishing.org/journal/rsob
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mtDNA mutants versus wild-type; we are likely only to be
able to observe expansion of point mutations in continuously
dividing culture; and many aspects of cell biology (mitochon-
drial dynamics, mtDNA replication rate etc.) we observe in
one cell type may not be representative of others in vivo in par-
ticular post-mitotic cells (e.g. skeletal muscle fibres, neurons).
One alternative for this last point is the growing work using
patient derived induced pluripotent stem cells (iPSCs) [97],
which can be differentiated into any cell type and also used
to generate 2D or 3D co-cultures that are more representative
of tissues. Such cultures are technically difficult to establish
and maintain, however, and still suffer from many of the
disadvantages listed above.
Animalmodelshave theadvantageofprovidingphysiologi-
cally relevant conditions and cell types. For practical reasons,
mouse models are a popular choice, however many do not
accumulate the same levels of respiratory chain deficiency as
humans. Differences between mouse and human tissue prob-
ably arise because of their much shorter lifespan but could
also be due to significant difference in cell types (e.g. fibre
type composition in muscle) and possibly mtDNA population
size. This is important to consider when interpreting findings
from animal models since, for example, Elson et al. [18] demon-
strated a slower increase of mtDNA mutation load when
the cellular mtDNA population is larger. Another advantage
of animalmodels is the ability tomanipulate process oruse tech-
niques to label cellular components and thus test hypotheses.
However, animal models still present similar issues to human
tissue samples since sampling tissue from mice still requires
cross-sectional observations at single time points.
In addition to mouse models, Caenorhabditis elegans has
been used in several studies which looked to investigate the
clonal expansion of deleted mtDNA molecules [74,98] and
mtDNA point mutations [99]. Caenorhabditis elegans, similar
to mice, has a shorter lifespan than humans and as such does
not have sufficient time for sporadic mtDNA mutations to
clonally expand in wild-type animals [100]. However it pro-
vides a cost-effective means to investigate some of the
possible selective pressures that could impact clonal expansion
from low mutation loads in physiologically relevant tissues,
such as the activation of retrograde signalling responses, and
changes in mitochondrial biogenesis or mitophagy [74,98].
6.2. Mathematical models
Work on mathematical models of clonal expansion has contin-
ued since Chinnery et al. first modelled relaxed replication
demonstrating that heteroplasmy can shift quickly over a
short period of time [17]. This work was developed further by
Elson et al. to explain between-cell heterogeneity in mtDNA
mutation loaddynamics [18]. Kowald&Kirkwood add the pro-
cess of transcription to the same underlying model [21]. Stamp
et al. incorporate the effect of asymmetric division of mitotic
stem cells alongwith randomdrift [38]. Johnston & Jones consi-
der the effect of various copy number control schemes on
theoretical mutation load distributions between cells [101].
As stated before, random genetic drift presents an impor-
tant, simple null hypothesis to which, new models can be
compared. Indeed, while it does seem to explain clonal expan-
sion of mtDNA point mutations in colonic crypts, it does not
seem to fully explain clonal expansion of mtDNA deletions
in post-mitotic cells. However, it is possible and indeedlikely that this is due to the specific assumptions embedded
in the modelling by Elson et al. [18] about fixed mtDNA copy
number, copy number control, mtDNA mutation rate,
mtDNA half-life and mixing of mtDNA populations within
the cell, all of which we still know very little about. Further-
more, these parameters are likely to vary between different
tissues and cell types, and so inferences based solely on infor-
mation from other cell types and tissues should be avoided. In
order to assess the predictions from the random genetic drift
hypothesis, we need to take intrinsic stochasticity as well as
uncertainty about parameter values and processes into con-
sideration, ideally through formal statistical inference, using
methods that can handle parameter uncertainty
and stochastic models. Henderson et al. demonstrate the
computational and analytical difficulties behind inference for
a model of mtDNA population dynamics [102]. Indeed,
Bayesian inference for stochastic simulation models remains
an active area of research in applied statistics [103–105], but
there are several tools currently available to help with exact
Bayesian inference for deterministic models [106–108].
Building amathematicalmodel helps us to be explicit about
our mechanistic hypothesis about how a system works. Simu-
lating from that model helps us make predictions about its
consequences. We can then test the hypothesis by comparing
predictions with experimental observations.
We expect that in order to make progress, particularly on
the difficult problem of understanding the expansion of
mutations in post-mitotic tissue (e.g. muscle fibres and neur-
ons), we will need to incorporate our considerable uncertainty
about the process of clonal expansion into our analysis of simu-
lation model output. To make robust, statistical comparisons
between predictions and observations, we need to include
uncertainty about parameters into simulations from a model,
propagating that uncertainty forward to uncertainty about pre-
dicted outputs. However, direct experimental observations of
parameters relevant to clonal expansion (particularly the rate
of mtDNA replication) is not currently possible. Assuming
a dynamic model and fitting its output to cross-sectional,
single-cell observations of copy number distributions and
mutation load distributions over time is an important approach
to learn about these processes in human cells.
Models are useful for bridging the gap betweenwhat can be
observed and the process of interest. In this case we can make
cross-sectional observations of mtDNA mutation load and
copy number in hundreds of heterogeneous single cells, some-
times at multiple time points. We can use mathematical models
to simulate mtDNA replication, including selection processes
and potentially cell loss, to predict what observed mutation
load distributions would look like under different hypotheses.
For example, Elson et al. [18] created a model based on the
random drift hypothesis and demonstrated that, for a plausible
set of parameters (mtDNA copy number, mtDNA replication
rate, mtDNA mutation rate), over a human lifespan, the
proportion of post-mitotic cells where mutations arose de
novo and expanded clonally by neutral drift during relaxed
replication increased significantly with age.
Writing amodel to describe clonal expansion forces us to be
explicit about the mtDNA population we have in mind. For
example, the model simulations carried out by Elson et al. [18]
are of random genetic drift during relaxed replication, in well-
mixed cells, with a fixed rate of mutation, a fixed replication
rate and a fixed copy number. In reality, all of these parameters
are likely to change with tissue or cell type and might even
royalsocietypublishing.org/journal/rsob
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tions with spatial data (e.g. the spatial distribution of mutation
loads along massive muscle fibres) then we need to update
the model to include those spatial effects. Work by Elson et al.
[18] and subsequent models (e.g. model of mtDNA population
dynamics inmitotic epithelial cryptsbyStamp et al. [38]) assume
perfect control of mtDNA copy number. If copy number is not
tightly controlled, then it is likely that mtDNA population
dynamics will include nonlinear bottleneck effects.
The point here is that, even under the label ‘random genetic
drift hypothesis’, there is quite awide range of different ways to
represent the mechanisms underlying this hypothesis. It is
important to explore the full range of plausible mechanisms
(formal model selection) as well as to explore the full range of
plausible parameter values (formal parameter inference). In
some cases, it is possible to frame the choice between different
mechanisms or even different hypotheses as parameter infer-
ence. For example, including selective advantage into a model
of random genetic drift, it could be possible to infer statistically
that the parameter representing selective advantage is not sig-
nificantly different from zero, thereby rejecting that hypothesis.
Experimental data derived from patient tissue are difficult
to gather and are very valuable. By carrying out parameter
inference for a specific model and validating its predictions
by comparing with data [102], we make the best use we can
of patient tissue; for example, we can use this approach to esti-
mate tissue-specific mutation rates, mtDNA copy number,
replication rates and the strength of any selective advantage,
together with our uncertainty about them, even for individual
patients. Although it is difficult work, requiring experimental
design specifically targeted at a particular model and challen-
ging computation, the payback is thatwe can infer estimates for
parameters that are difficult to access as well as make and
assess quantitative predictions of mutation load distributions
(and their uncertainty) which we can use to assess the validity
of models and their underlying hypotheses. Learning about
long-term dynamic processes driving clonal expansion
throughout human lifespans is extremely difficult. However,
the availability of rich, single-celled datasets makes this
approach more realistic and promising than ever before.7. Conclusion and future perspectives
The ongoing revolution in technology allows single-cell obser-
vations of mtDNA populations and allows us to discriminatemore precisely between hypotheses about clonal expansion.
Single-cell analysis provides us with the opportunity to quan-
tify the distribution of cellular outcomes within an individual
patient. To further our understanding of clonal expansion,
we should take advantage of these rich data by comparing
directly with distributed model predictions. We should look
to re-visit older hypotheses such as random drift, as well as
newer ideas such as perinuclear niche hypothesis by building
and assessing mathematical models. We would like to alert
our computational biology colleagues that the impossibility
of direct observation of clonal expansion makes this a field
where modelling work will make a real and important contri-
bution. While learning about clonal expansion, particularly in
post-mitotic cells, the modelling, statistical and computational
challenges will be difficult but rewarding. By understanding
this puzzling phenomenon that holds important pathological
relevance to a range of diseases, we can then start to look for
ways to slow or indeed halt this process. Such a therapeutic
target would have extensive applications; however, it will
also be important to understand key differences between dis-
eases, tissues and mutations if we are to hold any hope of
developing treatments.
Ethics. Muscle biopsies fromquadricepswere obtained via needle biopsy
under local anaesthesia. Ethical approval was granted by the Newcastle
and North Tyneside local research ethics committees (reference 2002/
205), and prior informed consent was obtained from each participant.
Formalin-fixed paraffin-embedded (FFPE) human midbrain tissue
sections were obtained from the Newcastle Brain Tissue Resource
(NBTR, https://nbtr.ncl.ac.uk/), with approval from the Local
Research Ethics Committee and adherence to the Medical Research
Council’s (MRC) Guidelines on the use of human tissue in medical
research. Colon tissuewas collected during surgerywith prior informed
consent and was approved by the Joint Ethics Committee of Newcastle
and North Tyneside Health Authority (2001/188) and the National
Research Ethics Committee London-Stanmore (11/LO/1613).
Data accessibility. This article does not contain any additional data.
Authors’ contributions. A.E.V., C.L., L.G. and A.K.R. contributed to draft-
ing the manuscript. A.E.V. drafted the figures. All authors critically
revised the manuscript and approved the final version.
Competing interests. We declare we have no competing interests.
Funding. This work was supported by the Wellcome Centre for Mito-
chondrial Research (203105/Z/16/Z). A.E.V. is in receipt of a Sir
Henry Wellcome Fellowship (215888/Z/19/Z). A.K.R. is in receipt
of a Senior Parkinson’s UK Fellowship (F-1401).
Acknowledgements. The authors would like to thank Anna Smith and Dr
Chun Chen for contributing the images of colonic crypts and neur-
ons, respectively. We would also like to thank Paula Rutter for
redrawing figure 1.References1. Esser C et al. 2004 A genome phylogeny for
mitochondria among α-proteobacteria and a
predominantly eubacterial ancestry of yeast nuclear
genes. Mol. Biol. Evol. 21, 1643–1660. (doi:10.
1093/molbev/msh160)
2. de Grey AD. 1997 A proposed refinement of the
mitochondrial free radical theory of aging. BioEssays
19, 161–166. (doi:10.1002/bies.950190211)
3. Anderson S et al. 1981 Sequence and organization
of the human mitochondrial genome. Nature 290,
457–465. (doi:10.1038/290457a0)4. Novick RP, Clowes RC, Cohen SN, Curtiss R, Datta N,
Falkow S. 1976 Uniform nomenclature for bacterial
plasmids: a proposal. Bacteriol. Rev. 40, 168–189.
(doi:10.1128/MMBR.40.1.168-189.1976)
5. Bogenhagen D, Clayton DA. 1977 Mouse L cell
mitochondrial DNA molecules are selected randomly
for replication throughout the cell cycle. Cell 11,
719–727. (doi:10.1016/0092-8674(77)90286-0)
6. Nijtmans LG, Henderson NS, Attardi G, Holt IJ. 2001
Impaired ATP synthase assembly associated with a
mutation in the human ATP synthase subunit 6gene. J. Biol. Chem. 276, 6755–6762. (doi:10.1074/
jbc.M008114200)
7. Mattiazzi M, Vijayvergiya C, Gajewski CD,
DeVivo DC, Lenaz G, Wiedmann M, Manfredi G.
2004 The mtDNA T8993G (NARP) mutation
results in an impairment of oxidative
phosphorylation that can be improved by
antioxidants. Hum. Mol. Genet. 13, 869–879.
(doi:10.1093/hmg/ddh103)
8. Monnot S et al. 2011 Segregation of mtDNA
throughout human embryofetal development:
royalsocietypublishing.org/journal/rsob
Open
Biol.10:200061
10m.3243A>G as a model system. Hum. Mutat. 32,
116–125. (doi:10.1002/humu.21417)
9. Campbell G, Krishnan KJ, Deschauer M, Taylor RW,
Turnbull DM. 2014 Dissecting the mechanisms
underlying the accumulation of mitochondrial
DNA deletions in human skeletal muscle. Hum.
Mol. Genet. 23, 4612–4620. (doi:10.1093/hmg/
ddu176)
10. Taylor RW et al. 2003 Mitochondrial DNA mutations
in human colonic crypt stem cells. J. Clin. Invest.
112, 1351–1360. (doi:10.1172/JCI19435)
11. Oldfors A, Moslemi AR, Fyhr IM, Holme E, Larsson
NG, Lindberg C. 1995 Mitochondrial DNA deletions
in muscle fibers in inclusion body myositis.
J. Neuropathol. Exp. Neurol. 54, 581–587. (doi:10.
1097/00005072-199507000-00012)
12. Bender A et al. 2006 High levels of mitochondrial
DNA deletions in substantia nigra neurons in aging
and Parkinson disease. Nat. Genet. 38, 515–517.
(doi:10.1038/ng1769)
13. Nido GS, Dolle C, Flones I, Tuppen HA, Alves G,
Tysnes OB, Haugarvoll K, Tzoulis C. 2018 Ultradeep
mapping of neuronal mitochondrial deletions in
Parkinson’s disease. Neurobiol. Aging 63, 120–127.
(doi:10.1016/j.neurobiolaging.2017.10.024)
14. Rygiel KA et al. 2016 Complex mitochondrial DNA
rearrangements in individual cells from patients
with sporadic inclusion body myositis. Nucleic Acids
Res. 44, 5313–5329. (doi:10.1093/nar/gkw382)
15. Lehmann D et al. 2019 Understanding
mitochondrial DNA maintenance disorders at the
single muscle fibre level. Nucleic Acids Res. 47,
7430–7443. (doi:10.1093/nar/gkz472)
16. Dolle C et al. 2016 Defective mitochondrial DNA
homeostasis in the substantia nigra in Parkinson
disease. Nat. Commun. 7, 13548. (doi:10.1038/
ncomms13548)
17. Chinnery PF, Samuels DC. 1999 Relaxed replication
of mtDNA: a model with implications for the
expression of disease. Am. J. Hum. Genet. 64,
1158–1165. (doi:10.1086/302311)
18. Elson JL, Samuels DC, Turnbull DM, Chinnery PF.
2001 Random intracellular drift explains the clonal
expansion of mitochondrial DNA mutations with
age. Am. J. Hum. Genet. 68, 802–806. (doi:10.1086/
318801)
19. Wallace DC. 1989 Mitochondrial DNA mutations and
neuromuscular disease. Trends Genet. 5, 9–13.
(doi:10.1016/0168-9525(89)90005-X)
20. Yoneda M, Chomyn A, Martinuzzi A, Hurko O,
Attardi G. 1992 Marked replicative advantage of
human mtDNA carrying a point mutation that
causes the MELAS encephalomyopathy. Proc. Natl
Acad. Sci. USA 89, 11 164–11 168. (doi:10.1073/
pnas.89.23.11164)
21. Kowald A, Kirkwood TBL. 2014 Transcription could
be the key to the selection advantage of
mitochondrial deletion mutants in aging. Proc. Natl
Acad. Sci. USA 111, 2972–2977. (doi:10.1073/pnas.
1314970111)
22. Kowald A, Kirkwood TBL. 2018 Resolving the
enigma of the clonal expansion of mtDNA deletions.
Genes 9, 126. (doi:10.3390/genes9030126)23. Vincent AE et al. 2018 Subcellular origin of
mitochondrial DNA deletions in human skeletal
muscle. Ann. Neurol. 84, 289–301. (doi:10.1002/
ana.25288)
24. Coller HA, Khrapko K, Bodyak ND, Nekhaeva E,
Herrero-Jimenez P, Thilly WG. 2001 High frequency
of homoplasmic mitochondrial DNA mutations in
human tumors can be explained without selection.
Nat. Genet. 28, 147–150. (doi:10.1038/88859)
25. Kimura M. 1968 Evolutionary rate at the molecular
level. Nature 217, 624–626. (doi:10.1038/
217624a0)
26. Miquel J, Economos AC, Fleming J, Johnson Jr JE.
1980 Mitochondrial role in cell aging. Exp. Gerontol.
15, 575–591. (doi:10.1016/0531-5565(80)90010-8)
27. Wang D, Kreutzer DA, Essigmann JM. 1998
Mutagenicity and repair of oxidative DNA damage:
insights from studies using defined lesions. Mutat.
Res. 400, 99–115. (doi:10.1016/S0027-
5107(98)00066-9)
28. Bohr VA. 2002 Repair of oxidative DNA damage in
nuclear and mitochondrial DNA, and some changes
with aging in mammalian cells. Free Radic. Biol.
Med. 32, 804–812. (doi:10.1016/S0891-
5849(02)00787-6)
29. Greaves LC et al. 2014 Clonal expansion of early to
mid-life mitochondrial DNA point mutations drives
mitochondrial dysfunction during human ageing.
PLoS Genet. 10, e1004620. (doi:10.1371/journal.
pgen.1004620)
30. Kennedy SR, Salk JJ, Schmitt MW, Loeb LA. 2013
Ultra-sensitive sequencing reveals an age-related
increase in somatic mitochondrial mutations that
are inconsistent with oxidative damage. PLoS Genet.
9, e1003794. (doi:10.1371/journal.pgen.1003794)
31. Zheng W, Khrapko K, Coller HA, Thilly WG, Copeland
WC. 2006 Origins of human mitochondrial point
mutations as DNA polymerase γ-mediated errors.
Mutat. Res. 599, 11–20. (doi:10.1016/j.mrfmmm.
2005.12.012)
32. Kauppila TES, Kauppila JHK, Larsson NG. 2017
Mammalian mitochondria and aging: an
update. Cell Metab. 25, 57–71. (doi:10.1016/j.cmet.
2016.09.017)
33. Nekhaeva E, Bodyak ND, Kraytsberg Y, McGrath SB,
Van Orsouw NJ, Pluzhnikov A, Wei JY, Vijg J,
Khrapko K. 2002 Clonally expanded mtDNA
point mutations are abundant in individual
cells of human tissues. Proc. Natl Acad. Sci. USA 99,
5521–5526. (doi:10.1073/pnas.072670199)
34. Fellous TG et al. 2009 A methodological approach
to tracing cell lineage in human epithelial
tissues. Stem Cells 27, 1410–1420. (doi:10.1002/
stem.67)
35. Greaves LC, Barron MJ, Plusa S, Kirkwood TB,
Mathers JC, Taylor RW, Turnbull DM. 2010 Defects in
multiple complexes of the respiratory chain are
present in ageing human colonic crypts. Exp.
Gerontol. 45, 573–579. (doi:10.1016/j.exger.2010.
01.013)
36. McDonald SA et al. 2008 Mechanisms of field
cancerization in the human stomach: the expansion
and spread of mutated gastric stem cells.Gastroenterology 134, 500–510. (doi:10.1053/j.
gastro.2007.11.035)
37. Blackwood JK et al. 2011 In situ lineage tracking of
human prostatic epithelial stem cell fate reveals a
common clonal origin for basal and luminal cells.
J. Pathol. 225, 181–188. (doi:10.1002/path.2965)
38. Stamp C et al. 2018 Predominant asymmetrical
stem cell fate outcome limits the rate of niche
succession in human colonic crypts. EBioMedicine
31, 166–173. (doi:10.1016/j.ebiom.2018.04.017)
39. Moad M et al. 2017 Multipotent basal stem cells,
maintained in localized proximal niches, support
directed long-ranging epithelial flows in human
prostates. Cell Rep. 20, 1609–1622. (doi:10.1016/j.
celrep.2017.07.061)
40. Nooteboom M, Johnson R, Taylor RW, Wright NA,
Lightowlers RN, Kirkwood TBL, Mathers JC, Turnbull
DM, Greaves LC. 2010 Age-associated mitochondrial
DNA mutations lead to small but significant
changes in cell proliferation and apoptosis in
human colonic crypts. Aging Cell 9, 96–99. (doi:10.
1111/j.1474-9726.2009.00531.x)
41. Kujoth GC et al. 2005 Mitochondrial DNA mutations,
oxidative stress, and apoptosis in mammalian aging.
Science 309, 481–484. (doi:10.1126/science.1112125)
42. Trifunovic A et al. 2004 Premature ageing in mice
expressing defective mitochondrial DNA polymerase.
Nature 429, 417–423. (doi:10.1038/nature02517)
43. Vermulst M, Wanagat J, Kujoth GC, Bielas JH,
Rabinovitch PS, Prolla TA, Loeb LA. 2008 DNA
deletions and clonal mutations drive premature
aging in mitochondrial mutator mice. Nat. Genet.
40, 392–394. (doi:10.1038/ng.95)
44. Baines HL, Turnbull DM, Greaves LC. 2014 Human
stem cell aging: do mitochondrial DNA mutations
have a causal role? Aging Cell 13, 201–205. (doi:10.
1111/acel.12199)
45. Fox RG, Magness S, Kujoth GC, Prolla TA, Maeda N.
2012 Mitochondrial DNA polymerase editing
mutation, PolgD257A, disturbs stem-progenitor cell
cycling in the small intestine and restricts excess fat
absorption. Am. J. Physiol. Gastrointest. Liver Physiol.
302, G914–G924. (doi:10.1152/ajpgi.00402.2011)
46. Norddahl GL, Pronk CJ, Wahlestedt M, Sten G,
Nygren JM, Ugale A, Sigvardsson M, Bryder D. 2011
Accumulating mitochondrial DNA mutations drive
premature hematopoietic aging phenotypes distinct
from physiological stem cell aging. Cell stem cell 8,
499–510. (doi:10.1016/j.stem.2011.03.009)
47. Ahlqvist KJ et al. 2012 Somatic progenitor cell
vulnerability to mitochondrial DNA mutagenesis
underlies progeroid phenotypes in Polg mutator
mice. Cell Metab. 15, 100–109. (doi:10.1016/j.cmet.
2011.11.012)
48. Su T, Turnbull DM, Greaves LC. 2018 Roles of
mitochondrial DNA mutations in stem cell ageing.
Genes 9, 182. (doi:10.3390/genes9040182)
49. Grady JP et al. 2018 mtDNA heteroplasmy level and
copy number indicate disease burden in m.3243A>
G mitochondrial disease. EMBO Mol. Med. 10,
e8262. (doi:10.15252/emmm.201708262)
50. Olsson C, Johnsen E, Nilsson M, Wilander E, Syvanen
AC, Lagerstrom-Fermer M. 2001 The level of the
royalsocietypublishing.org/journal/rsob
Open
Biol.10:200061
11mitochondrial mutation A3243G decreases upon
ageing in epithelial cells from individuals with
diabetes and deafness. Eur. J. Hum. Genet. 9,
917–921. (doi:10.1038/sj.ejhg.5200742)
51. Rahman S, Poulton J, Marchington D, Suomalainen
A. 2001 Decrease of 3243 A→G mtDNA mutation
from blood in MELAS syndrome: a longitudinal
study. Am. J. Hum. Genet. 68, 238–240. (doi:10.
1086/316930)
52. Frederiksen AL, Andersen PH, Kyvik KO, Jeppesen
TD, Vissing J, Schwartz M. 2006 Tissue specific
distribution of the 3243A→G mtDNA mutation.
J. Med. Genet. 43, 671–677. (doi:10.1136/jmg.2005.
039339)
53. Reeve AK, Krishnan KJ, Elson JL, Morris CM, Bender
A, Lightowlers RN, Turnbull DM. 2008 Nature of
mitochondrial DNA deletions in substantia nigra
neurons. Am. J. Hum. Genet. 82, 228–235. (doi:10.
1016/j.ajhg.2007.09.018)
54. Shoffner JM, Lott MT, Voljavec AS, Soueidan SA,
Costigan DA, Wallace DC. 1989 Spontaneous Kearns-
Sayre/chronic external ophthalmoplegia plus
syndrome associated with a mitochondrial DNA
deletion: a slip-replication model and metabolic
therapy. Proc. Natl Acad. Sci. USA 86, 7952–7956.
(doi:10.1073/pnas.86.20.7952)
55. Krishnan KJ et al. 2008 What causes mitochondrial
DNA deletions in human cells? Nat. Genet. 40,
275–279. (doi:10.1038/ng.f.94)
56. Fukui H, Moraes CT. 2009 Mechanisms of formation
and accumulation of mitochondrial DNA deletions in
aging neurons. Hum. Mol. Genet. 18, 1028–1036.
(doi:10.1093/hmg/ddn437)
57. Tadi SK, Sebastian R, Dahal S, Babu RK, Choudhary
B, Raghavan SC. 2016 Microhomology-mediated
end joining is the principal mediator of double-
strand break repair during mitochondrial DNA
lesions. Mol. Biol. Cell 27, 223–235. (doi:10.1091/
mbc.e15-05-0260)
58. Lieber MR. 2010 The mechanism of double-strand
DNA break repair by the nonhomologous DNA end-
joining pathway. Annu. Rev. Biochem. 79, 181–211.
(doi:10.1146/annurev.biochem.052308.093131)
59. Persson Ö et al. 2019 Copy-choice recombination
during mitochondrial L-strand synthesis causes DNA
deletions. Nat. Commun. 10, 759. (doi:10.1038/
s41467-019-08673-5)
60. Nissanka N, Minczuk M, Moraes CT. 2019
Mechanisms of mitochondrial DNA deletion
formation. Trends Genet. 35, 235–244. (doi:10.
1016/j.tig.2019.01.001)
61. Herbers E, Kekalainen NJ, Hangas A, Pohjoismaki JL,
Goffart S. 2019 Tissue specific differences in
mitochondrial DNA maintenance and expression.
Mitochondrion 44, 85–92. (doi:10.1016/j.mito.2018.
01.004)
62. Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ,
Reynolds R, Howell O, Lassmann H, Turnbull DM,
Mahad DJ. 2011 Mitochondrial DNA deletions and
neurodegeneration in multiple sclerosis. Ann.
Neurol. 69, 481–492. (doi:10.1002/ana.22109)
63. Krishnan KJ, Ratnaike TE, De Gruyter HL, Jaros E,
Turnbull DM. 2012 Mitochondrial DNA deletionscause the biochemical defect observed in
Alzheimer’s disease. Neurobiol. Aging 33,
2210–2214. (doi:10.1016/j.neurobiolaging.
2011.08.009)
64. Keeney PM, Bennett Jr JP. 2010 ALS spinal neurons
show varied and reduced mtDNA gene copy
numbers and increased mtDNA gene deletions. Mol.
Neurodegener. 5, 21. (doi:10.1186/1750-1326-5-21)
65. Bua E, Johnson J, Herbst A, Delong B, McKenzie D,
Salamat S, Aiken JM. 2006 Mitochondrial DNA-
deletion mutations accumulate intracellularly to
detrimental levels in aged human skeletal muscle
fibers. Am. J. Hum. Genet. 79, 469–480. (doi:10.
1086/507132)
66. Bender A, Schwarzkopf RM, McMillan A, Krishnan
KJ, Rieder G, Neumann M, Elstner M, Turnbull DM,
Klopstock T. 2008 Dopaminergic midbrain neurons
are the prime target for mitochondrial DNA
deletions. J. Neurol. 255, 1231–1235. (doi:10.1007/
s00415-008-0892-9)
67. Wei Soong N, Hinton DR, Cortopassi G, and Arnheim
N. 1992 Mosaicism for a specific somatic
mitochondrial DNA mutation in adult human brain.
Nat. Genet. 2, 318–323. (doi:10.1038/ng1292-318)
68. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C,
Kowall NW, Khrapko K. 2006 Mitochondrial DNA
deletions are abundant and cause functional
impairment in aged human substantia
nigra neurons. Nat. Genet. 38, 518–520. (doi:10.
1038/ng1778)
69. Itoh K, Weis S, Mehraein P, Müller-Höcker J. 1997
Defects of cytochrome c oxidase in the substantia
nigra of Parkinson’s disease: an
immunohistochemical and morphometric study.
Mov. Disord. 12, 9–16. (doi:10.1002/mds.
870120104)
70. Fearnley JM, Lees AJ. 1991 Ageing and Parkinson’s
disease: substantia nigra regional selectivity.
Brain 114(Pt 5), 2283–2301. (doi:10.1093/brain/
114.5.2283)
71. Brierley EJ, Johnson MA, Lightowlers RN, James OF,
Turnbull DM 1998 Role of mitochondrial DNA
mutations in human aging: implications for the
central nervous system and muscle. Ann. Neurol. 43,
217–223. (doi:10.1002/ana.410430212)
72. Diaz F, Bayona-Bafaluy MP, Rana M, Mora M, Hao
H, Moraes CT. 2002 Human mitochondrial DNA with
large deletions repopulates organelles faster than
full-length genomes under relaxed copy number
control. Nucleic Acids Res. 30, 4626–4633. (doi:10.
1093/nar/gkf602)
73. Moraes CT, Kenyon L, Hao H. 1999 Mechanisms of
human mitochondrial DNA maintenance: the
determining role of primary sequence and length
over function. Mol. Biol. Cell 10, 3345–3356.
(doi:10.1091/mbc.10.10.3345)
74. Gitschlag BL, Kirby CS, Samuels DC, Gangula RD,
Mallal SA, Patel MR. 2016 Homeostatic responses
regulate selfish mitochondrial genome dynamics in
C. elegans. Cell Metab. 24, 91–103. (doi:10.1016/j.
cmet.2016.06.008)
75. Damas J, Carneiro J, Amorim A, Pereira F. 2013
MitoBreak: the mitochondrial DNA breakpointsdatabase. Nucleic Acids Res. 42, D1261–D1268.
(doi:10.1093/nar/gkt982)
76. Khan NA et al. 2017 mTORC1 regulates
mitochondrial integrated stress response
and mitochondrial myopathy progression. Cell
Metab. 26, 419–428.e415. (doi:10.1016/j.cmet.
2017.07.007)
77. Davis AF, Clayton DA. 1996 In situ localization of
mitochondrial DNA replication in intact mammalian
cells. J. Cell Biol. 135, 883–893. (doi:10.1083/jcb.
135.4.883)
78. Picard M, White K, Turnbull DM. 2013 Mitochondrial
morphology, topology, and membrane interactions
in skeletal muscle: a quantitative three-dimensional
electron microscopy study. J. Appl. Physiol. 114,
161–171. (doi:10.1152/japplphysiol.01096.2012)
79. Mishra P, Varuzhanyan G, Pham AH, Chan DC.
2015 Mitochondrial dynamics is a distinguishing
feature of skeletal muscle fiber types and
regulates organellar compartmentalization.
Cell Metab. 22, 1033–1044. (doi:10.1016/j.cmet.
2015.09.027)
80. Eisner V, Lenaers G, Hajnóczky G. 2014
Mitochondrial fusion is frequent in skeletal muscle
and supports excitation-contraction coupling.
J. Cell Biol. 205, 179–195. (doi:10.1083/jcb.
201312066)
81. Chen H, Vermulst M, Wang YE, Chomyn A, Prolla
TA, McCaffery JM, Chan DC. 2010 Mitochondrial
fusion is required for mtDNA stability in skeletal
muscle and tolerance of mtDNA mutations. Cell
141, 280–289. (doi:10.1016/j.cell.2010.02.026)
82. Kang JS, Tian JH, Pan PY, Zald P, Li C, Deng C,
Sheng ZH. 2008 Docking of axonal mitochondria by
syntaphilin controls their mobility and affects short-
term facilitation. Cell 132, 137–148. (doi:10.1016/j.
cell.2007.11.024)
83. Miller KE, Sheetz MP. 2004 Axonal mitochondrial
transport and potential are correlated. J. Cell Sci.
117, 2791–2804. (doi:10.1242/jcs.01130)
84. Verburg J, Hollenbeck PJ. 2008 Mitochondrial
membrane potential in axons increases with local
nerve growth factor or semaphorin signaling.
J. Neurosci. 28, 8306–8315. (doi:10.1523/
JNEUROSCI.2614-08.2008)
85. McWilliams TG, Prescott AR, Allen GF, Tamjar J,
Munson MJ, Thomson C, Muqit MM, Ganley IG.
2016 mito-QC illuminates mitophagy and
mitochondrial architecture in vivo. J. Cell Biol. 214,
333–345. (doi:10.1083/jcb.201603039)
86. Lee HF, Lee HJ, Chi CS, Tsai CR, Chang TK, Wang CJ.
2007 The neurological evolution of Pearson
syndrome: case report and literature review.
Eur. J. Paediatr. Neurol. 11, 208–214. (doi:10.1016/
j.ejpn.2006.12.008)
87. Rocha MC et al. 2018 Pathological mechanisms
underlying single large-scale mitochondrial DNA
deletions. Ann. Neurol. 83, 115–130. (doi:10.1002/
ana.25127)
88. Pistilli D, di Gioia CR, D’Amati G, Sciacchitano S,
Quaglione R, Quitadamo R, Casali C, Gallo P,
Santorelli FM. 2003 Detection of deleted
mitochondrial DNA in Kearns-Sayre syndrome using
royalsocietypublishing.org/journal/rsob
Open
Biol.10:200061
12laser capture microdissection. Hum. Pathol. 34,
1058–1061. (doi:10.1053/S0046-8177(03)00344-7)
89. O0Leary MFN, Vainshtein A, Carter HN, Zhang Y,
Hood DA. 2012 Denervation-induced mitochondrial
dysfunction and autophagy in skeletal muscle of
apoptosis-deficient animals. Am. J. Physiol. Cell
Physiol. 303, C447–C454. (doi:10.1152/ajpcell.
00451.2011)
90. Schwartz LM. 2019 Skeletal muscles do not undergo
apoptosis during either atrophy or programmed
cell death-revisiting the myonuclear domain
hypothesis. Front. Physiol. 9, 1887. (doi:10.3389/
fphys.2018.01887)
91. Relaix F, Zammit PS. 2012 Satellite cells are
essential for skeletal muscle regeneration: the cell
on the edge returns centre stage. Development 139,
2845. (doi:10.1242/dev.069088)
92. de Laat P, Koene S, van den Heuvel LPWJ,
Rodenburg RJT, Janssen MCH, Smeitink JAM. 2012
Clinical features and heteroplasmy in blood, urine
and saliva in 34 Dutch families carrying the
m.3243A > G mutation. J. Inherit. Metab. Dis. 35,
1059–1069. (doi:10.1007/s10545-012-9465-2)
93. Shanske S, Moraes CT, Lombes A, Miranda AF,
Bonilla E, Lewis P, Whelan MA, Ellsworth CA,
DiMauro S. 1990 Widespread tissue distribution of
mitochondrial DNA deletions in Kearns-Sayre
syndrome. Neurology 40, 24. (doi:10.1212/
WNL.40.1.24)
94. Brockington M, Alsanjari N, Sweeney MG, Morgan-
Hughes JA, Scaravilli F, Harding AE. 1995 Kearns-
Sayre syndrome associated with mitochondrial DNA
deletion or duplication: a molecular genetic andpathological study. J. Neurol. Sci. 131, 78–87.
(doi:10.1016/0022-510X(95)00091-F)
95. Chen C, Vincent AE, Blain AP, Smith AL, Turnbull
DM, Reeve AK. 2020 Investigation of mitochondrial
biogenesis defects in single substantia nigra
neurons using post-mortem human tissues.
Neurobiol. Dis. 134, 104631. (doi:10.1016/j.nbd.
2019.104631)
96. Ludwig LS et al. 2019 Lineage tracing in humans
enabled by mitochondrial mutations and single-cell
genomics. Cell 176, 1325–1339.e1322. (doi:10.
1016/j.cell.2019.01.022)
97. Russell OM et al. 2018 Preferential amplification of
a human mitochondrial DNA deletion in vitro and in
vivo. Sci. Rep. 8, 1799. (doi:10.1038/s41598-018-
20064-2)
98. Lin YF, Schulz AM, Pellegrino MW, Lu Y, Shaham S,
Haynes CM. 2016 Maintenance and propagation of a
deleterious mitochondrial genome by the
mitochondrial unfolded protein response. Nature
533, 416–419. (doi:10.1038/nature17989)
99. Konrad A, Thompson O, Waterston RH, Moerman
DG, Keightley PD, Bergthorsson U, Katju V. 2017
Mitochondrial mutation rate, spectrum and
heteroplasmy in Caenorhabditis elegans
spontaneous mutation accumulation lines of
differing population size. Mol. Biol. Evol. 34,
1319–1334.
100. Lakshmanan LN, Yee Z, Ng LF, Gunawan R, Halliwell
B, Gruber J. 2018 Clonal expansion of mitochondrial
DNA deletions is a private mechanism of aging in
long-lived animals. Aging Cell 17, e12814. (doi:10.
1111/acel.12814)101. Johnston IG, Jones NS. 2016 Evolution of cell-to-cell
variability in stochastic, controlled, heteroplasmic
mtDNA populations. Am. J. Hum. Genet. 99,
1150–1162. (doi:10.1016/j.ajhg.2016.09.016)
102. Henderson DA, Boys RJ, Krishnan KJ, Lawless C,
Wilkinson DJ. 2009 Bayesian emulation and
calibration of a stochastic computer model of
mitochondrial DNA deletions in substantia nigra
neurons. J. Am. Stat. Assoc. 104, 76–87. (doi:10.
1198/jasa.2009.0005)
103. Boys RJ, Wilkinson DJ, Kirkwood TBL. 2008 Bayesian
inference for a discretely observed stochastic kinetic
model. Stat. Comput. 18, 125–135. (doi:10.1007/
s11222-007-9043-x)
104. Golightly A, Wilkinson DJ. 2011 Bayesian parameter
inference for stochastic biochemical network models
using particle Markov chain Monte Carlo. Interface
focus 1, 807–820. (doi:10.1098/rsfs.2011.0047)
105. Wilkinson DJ. 2009 Stochastic modelling for
quantitative description of heterogeneous biological
systems. Nat. Rev. Genet. 10, 122–133. (doi:10.
1038/nrg2509)
106. Plummer M. 2003 A program for analysis of
Bayesian graphical models using Gibbs
sampling. Proceedings of the 3rd International
Workshop on Distributed Statistical Computing
(DSC 2003) 124(125.10), 1–10.
107. Carpenter B et al. 2017 Stan: a probabilistic
programming language. J. Stat. Softw. 76, 32.
(doi:10.18637/jss.v076.i01)
108. Tavaré S, Balding DJ, Griffiths RC, Donnelly P.
1997 Inferring coalescence times from DNA
sequence data. Genetics 145, 505–518.
